Induced sputum cell and fluid-phase indices of inflammation: comparison of treatment with dithiothreitol vs phosphate-buffered saline

Treatment of sputum with dithiothreitol (DTT) gives reliable measurements of cellular and fluid-phase markers of airway inflammation. We investigated the extent to which DTT treatment influences these measurements as compared with phosphate-buffered saline (PBS). Hypertonic saline-induced sputum, collected from 20 asthmatic subjects, was examined within 2 h. All portions which looked more solid (less fluid) than saliva were collected from the expectorate. The selected sputum was then divided into two portions: one treated with one volume of DTT and one volume of PBS, the other with two volumes of PBS. The filtrates were assessed blind for total and differential cell count, viability, and fluid-phase eosinophil cationic protein (ECP), fibrinogen, interleukin (IL)-5 and IL-8. Sputum treated with DTT compared with PBS had lower proportions of viable cells (median 66 versus 74%; p=0.003). In contrast, DTT-treated sputum had higher total cell counts (median 8.8 vs 2.8 x 10(6) mL(-1); p<0.001) and levels of ECP (median 1340 vs 584 mg x L(-1); p<0.001) The measurements were similar with respect to the proportion of eosinophils, neutrophils, lymphocytes, macrophages, and fluid-phase fibrinogen, IL-5 and IL-8. We conclude that dithiothreitol disperses cells more effectively and that this might account for the higher levels of eosinophil cationic protein. Dithiothreitol may affect cell viability, but the changes are not relevant with respect to cell counts. Additionally, dithiothreitol does not seem to influence the other measurements performed.

This article has been cited by other articles:

				S. D. Sagel, J. F. Chmiel, and M. W. Konstan Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417. [Abstract] [Full Text] [PDF]

				K. M. Beeh, J. Beier, N. Koppenhoefer, and R. Buhl Increased Glutathione Disulfide and Nitrosothiols in Sputum Supernatant of Patients With Stable COPD Chest, October 1, 2004; 126(4): 1116 - 1122. [Abstract] [Full Text] [PDF]

				M.M. Kelly, F.E. Hargreave, and G. Cox A method to preserve sputum for delayed examination Eur. Respir. J., December 1, 2003; 22(6): 996 - 1000. [Abstract] [Full Text] [PDF]

				I S Woolhouse, D L Bayley, and R A Stockley Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis Thorax, August 1, 2002; 57(8): 667 - 671. [Abstract] [Full Text] [PDF]

				Leader of the Working Group: A. Efthimiadis, A. Sp, Members of the Working Group:, Q. Hamid, M.M. Kelly, M. Linden, R. Louis, M.M.M. Pizzichini, E. Pizzichini, C. Ronchi, F. Van Overveld, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation Eur. Respir. J., July 1, 2002; 20(37_suppl): 19S - 23s. [Full Text] [PDF]

				Leader of the Working Group: M.M. Kelly, Members of the Working Group:, V. Keatings, R. Leigh, C. Peterson, J. Shute, P. Venge, and R. Djukanovic Analysis of fluid{-}phase mediators Eur. Respir. J., July 1, 2002; 20(37_suppl): 24S - 39s. [Full Text] [PDF]

				S. D. SAGEL, R. KAPSNER, I. OSBERG, M. K. SONTAG, and F. J. ACCURSO Airway Inflammation in Children with Cystic Fibrosis and Healthy Children Assessed by Sputum Induction Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1425 - 1431. [Abstract] [Full Text] [PDF]

				E. Grebski, C. Peterson, and T. C. Medici Effect of Physical and Chemical Methods of Homogenization on Inflammatory Mediators in Sputum of Asthma Patients Chest, May 1, 2001; 119(5): 1521 - 1525. [Abstract] [Full Text] [PDF]

				N. E. Alexis, J. Soukup, S. Nierkens, and S. Becker Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L369 - L375. [Abstract] [Full Text] [PDF]

				N Dauletbaev, J Rickmann, K Viel, R Buhl, T-O-F Wagner, and J Bargon Glutathione in induced sputum of healthy individuals and patients with asthma Thorax, January 1, 2001; 56(1): 13 - 18. [Abstract] [Full Text]

				A. Hill, S. Gompertz, and R. Stockley Factors influencing airway inflammation in chronic obstructive pulmonary disease Thorax, November 1, 2000; 55(11): 970 - 977. [Full Text]

				N. M Wilson, P. Bridge, A. Spanevello, and M. Silverman Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity Thorax, September 1, 2000; 55(9): 768 - 774. [Abstract] [Full Text]

				A Bhowmik, T A R Seemungal, R J Sapsford, J L Devalia, and J A Wedzicha Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease Thorax, November 1, 1998; 53(11): 953 - 956. [Abstract] [Full Text]